{
    "clinical_study": {
        "@rank": "168273", 
        "arm_group": [
            {
                "arm_group_label": "Oxytocin arm", 
                "arm_group_type": "Active Comparator", 
                "description": "Oxytocin alone administered which is current standard of care"
            }, 
            {
                "arm_group_label": "Oxytocin + syntometrine", 
                "arm_group_type": "Experimental", 
                "description": "Oxytocin plus syntometrine administered"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized trial comparing oxytocin versus oxytocin + syntometrine in the\n      prevention of post partum haemorrhage in patients undergoing caesarean section"
        }, 
        "brief_title": "A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Prevention of Post Partum Haemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Postpartum Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pregnant women delivering by caesarean section older than 18 years willing and able\n             to give informed consent\n\n        Exclusion Criteria:\n\n          -  \u2022 Women not willing or women not able to provide consent\n\n               -  Women who have a classical caesarean section\n\n               -  Women younger than 18 years of age\n\n               -  Women with any of the following conditions will be excluded (ergometrine\n                  contra-indicated in patients with these conditions).\n\n               -  Pre- eclampsia\n\n               -  Eclampsia,\n\n               -  Uncontrolled hypertension (hypertension defined as systolic blood pressure more\n                  than 140 mm Hg and diastolic blood pressure more than 90 mm Hg)\n\n               -  Any cardiac lesion\n\n               -  Impaired liver function\n\n               -  Impaired kidney function\n\n               -  Hypersensitivity to any of the active ingredients of the preparations that will\n                  be used (Syntometrine\u00ae or Syntocinon\u00ae)\n\n               -  Occlusive vascular disease\n\n               -  Autoimmune vasculitis"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02046499", 
            "org_study_id": "PPH Prevention Trial"
        }, 
        "intervention": [
            {
                "arm_group_label": "Oxytocin arm", 
                "description": "Oxytocin will be administered intravenously as per standard protocol", 
                "intervention_name": "Oxytocin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Oxytocin + syntometrine", 
                "description": "Oxytocin ergometrine will be administered intra-musculalry", 
                "intervention_name": "Oxytocin ergometrine", 
                "intervention_type": "Drug", 
                "other_name": "Syntometrine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ergonovine", 
                "Oxytocin", 
                "Syntometrine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Prevention, post partum haemorrhage", 
        "lastchanged_date": "January 23, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Pretoria", 
                    "country": "South Africa", 
                    "state": "Gauteng", 
                    "zip": "0001"
                }, 
                "name": "Kalafong Academic Hospital"
            }, 
            "investigator": {
                "last_name": "Sandy Koen, MBChB", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "South Africa"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section", 
        "overall_contact": {
            "email": "leon.snyman@up.ac.za", 
            "last_name": "Leon C Snyman, MBChB, MMed", 
            "phone": "+27834621818"
        }, 
        "overall_contact_backup": {
            "email": "sandy.koen@yahoo.com", 
            "last_name": "Sandy Koen, MBChB", 
            "phone": "+27767903940"
        }, 
        "overall_official": {
            "affiliation": "Department Obstetrics & Gynaecology, University of Pretoria, South Africa", 
            "last_name": "Leon C Snyman, MbChB MMed", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "South Africa: Human Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Estimated blood loss at caesarean section", 
            "measure": "Blood loss", 
            "safety_issue": "No", 
            "time_frame": "60 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02046499"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pretoria", 
            "investigator_full_name": "Leon Snyman", 
            "investigator_title": "Principal Specialist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Compare side effects experienced by women administered oxytocin compared to oxytocin plus ergometrine", 
                "measure": "Side effects of oxytocin compared to oxytocin + ergometrine", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "To determine the need for additional uterotonics to treat post partum haemorrhage", 
                "measure": "Need for additional uterotonics", 
                "safety_issue": "No", 
                "time_frame": "60 minutes"
            }, 
            {
                "description": "Compare the number of units blood required for transfusion between the two arms", 
                "measure": "Number of units blood transfused", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "University of Pretoria", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Pretoria", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}